AI for GLP-1 Persistence

Download case study
Solution brief

In the palm of your hand: the future of GLP-1 adherence

GLP-1 therapy works best when paired with behaviour change – but scaling personalised support across thousands of patients isn’t possible without AI. This infographic breaks down exactly how RxPx’s AI-powered tools are doing it right now.

  • The AI and digital health tools transforming GLP-1 therapy outcomes
  • How personalized insights and behaviour support drive adherence at scale
  • The key platform features your GLP-1 program needs – and how they work together

Trusted by leading life sciences companies

Biogen Janssen

Proven at scale.

GLP-1
Fastest-growing therapy category in pharma
50%+
Of GLP-1 patients discontinue within 12 months
AI+
Digital support shown to significantly improve persistence
Key platform features

How AI support GLP-1 patients at every stage.

RxPx has developed a suite of AI-powered, patient-facing features that deliver personalised care at scale. Here’s a preview of what the infographic covers.

Personalised health insights

AI analyses each patient’s behaviour, goals, and progress to surface tailored recommendations – making every interaction feel individual, not generic.

Behaviour & lifestyle support

Diet and behaviour modification are essential to GLP-1 outcomes. AI-powered nudges, education, and goal-setting tools reinforce the lifestyle changes that make therapy work.

Side effect management

AI-driven content and community support help patients navigate common GLP-1 side effects – reducing the likelihood of discontinuation driven by manageable symptoms.

Adherence monitoring & alerts

Real-time engagement data flags patients showing signs of disengagement – enabling timely outreach before they discontinue therapy.

Key takeways

What you’ll walk away knowing.

The AI tools available for GLP-1 support

A clear map of the AI and digital health tools now deployed in GLP-1 programs – and what each one does.

Why behaviour change can’t be an afterthought

The evidence behind combining GLP-1 therapy with digital behaviour support – and why one without the other underperforms.

The RxPx feature suite in detail

Every AI-powered patient feature RxPx has built – personalised insights, behaviour nudges, side effect support, adherence monitoring, and more.

How to apply this to your GLP-1 program

A practical starting point for evaluating which AI tools will have the greatest impact on adherence in your specific program.

What’s inside

A look at what you’ll discover.

Section 1

The GLP-1 adherence challenge

Why more than half of GLP-1 patients discontinue within 12 months – and the role behaviour change plays in closing the gap.

Section 2

How AI is changing the equation

The landscape of AI and digital health tools now available to support GLP-1 patients – from personalised insights to real-time engagement monitoring.

Unlock full access
to solution brief.

Get solution brief

Ready to see
the full results?

Download the complete infographic and get the full breakdown of how RxPx’s AI-powered platform supports GLP-1 patients at every stage of their journey.

  • The AI and digital health tools transforming GLP-1 therapy outcomes
  • How personalized insights and behaviour support drive adherence at scale
  • The key platform features your GLP-1 program needs – and how they work together
Continue learning

Related resources.